Firering Strategic Minerals: From explorer to producer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Started: poole, 17 Jun 2024 12:17
Last post: infinite44, 17 Jun 2024 15:21
Could well be Mennen buying more I suppose?
ANY ONE KNOW WHY THE BUYING INTEREST TODAY - ALREADY 78 TRADES?
Last post: Ambitiousbeef, 14 Jun 2024 12:12
Buys getting listed as sells now
15 may
20 may
13 June.
Last 3 RNs. Memen medical loading up. More to come more likely.
I thought that was yesterday or are they buying more?
Another buy from Mennen Medical, now up to 6%.
It is part of Redworth Capital Group
Redworth Capital is a multinational investment house with offices in Philadelphia (USA), Tel Aviv (ISR) and London (UK), engaged in diversified business segments: Medical Devices and Technologies, Real Estate and Entertainment
Started: Rich62, 28 May 2024 07:23
Last post: Rich62, 28 May 2024 07:23
This is great news. Board have finally realised its time for a change..
Board have removed Neil Campbell from CEO position and replaced him with Roy Davis, who becomes NE Chairman and Interim CEO. The company will update Shareholders about search for permanent CEO.
As a reminder when Davis joined NEDs in December his resume had the following information:
"Roy brings a wealth of commercial experience in medical devices companies and has a proven track record of successfully scaling companies and delivering substantial value for shareholders. He has held leadership positions at a number of publicly quoted med tech companies, including CEO of Optos plc, a leading retinal imaging device manufacturer, from 2008 to 2016 until its sale to Nikon for £259m in February 2015. From 2007 to 2008, Roy was CEO of Gyrus Group plc, a leader in minimally invasive surgery and visualisation, until its acquisition by Olympus Corporation in 2008 for $1.9 billion."
He gives me hope that he can grab IHC by the scruff of the neck. Make the necessary changes and get the company delivering some profit and value to shareholders
Started: Rich62, 1 May 2024 09:40
Last post: IT1954, 9 May 2024 15:20
I don't know something that anyone else should be aware of but what I do know is that if this company had been efficiently run then it would never have got into a situation where it's not recovering a large debt. Was the debt not insured because it would have been sensible to have done this. This is all quite basic stuff and it's completely pointless to make a sale if there's a chance that you won't be paid for it.
But a cash call might do the trick?
2reincarnated. The revenue was £41.23m for y/e 31 Jan 23. The expected revenue is £37m for y/e 31 Jan 24. Y/e 31 Jan 23 was profitable, just. I am not sure why we should be worried at the moment about the company going into administration, although clearly we will need to see the full figures for y/e 31 Jan 2024 before we can be certain either way. Do you know something that the rest of us should be aware of?
Takeover target yes correct!
But only by the administrators.
Got to be a takeover target at this level?
Started: IT1954, 1 May 2024 12:13
Last post: IT1954, 1 May 2024 12:13
The individuals running this business are obviously completely out of their depth and need to sell the company ASAP. I'm going to use the abbreviation WTU, meaning worse than useless. The alternative is that the company goes bust which shouldn't be allowed to happen and won't happen as long as the dead wood is cleared out.
Started: Stuartrm, 1 May 2024 07:23
Last post: ROCKETVI, 1 May 2024 11:38
First time I have seen this Company, but looking at their product ranges, have taken a small plunge. Looks like an over reaction regarding the sell-off.
Been in this since Inditherm days. Still believe in the product potentials. Missed out on an exit in the past when it was briefly around 150p but still think it's fundamentally good. Topped up this morning
Ludicrous over reaction on opening, down 45%.
The update is just a re-hash of January's update. The bank waiver has been extended for another year.
Yes, need to material export order to be fulfilled, but mid single digit growth and US business started positively.
Okay work to be done as results H2 loaded.
Got to be a takeover target if this management team can't fix a company with mainly non discretionary healthcare spend, surely?
The trading update is a bit of a mixed bag. Potential for the expected major order to fail to materialise is disappointing but (single digit) growth without that order, and decent performance in Florida, are both mildly encouraging. Hopefully the market reaction will not be too harsh, especially given that the share price is already pretty “bombed out”.
Started: IT1954, 31 Jan 2024 12:32
Last post: IT1954, 31 Jan 2024 12:32
This company does seem to be utterly useless / hopeless and it would be nice to think that it could be sold ASAP because the current lot of directors obviously haven't got a clue as to how to run a business. Anyone in agreement?
Started: poole, 29 Jan 2024 13:53
Last post: Rich62, 31 Jan 2024 08:08
I guess shortfall is around 10%. FY to end Jan 23 was rev £41.2m, FY to end Jan 22 was £41.4m
Today FY to end Jan 24 is £37.0m
Agreed, ragnarlothbrok. It would have been so simple to state what the size of the shortfall is.
Awful…. Bad news, lack of clarity is striking. It’s going to sting today. I reckon back down to low 40s. Capital raising probably now required, heavily discounted of course
Not the best trading update...
Not seen any tips, they do have results due soon (released mid Feb last year) and given they submitted for Fda approval for the SLE6000 ventilator almost 6 months ago expecting an update on that fairly soon too. I think it was oversold and was overdue a rerate anyway
Started: Rich62, 4 Jan 2024 07:30
Last post: Rich62, 4 Jan 2024 07:30
RNS out today - IHC buy Airon Corp for $2.5m ($1.5m from cash reserves and $1.0m to be paid at later date based on delivery of future revenues) Only a small outfit with revenue $1.4m, loss $0.4m, net assets $1.3m) however it will be a good platform to sell the SLE6000 neo natal ventillator, subject to FDA approval.
Looks a good acquisition to increase sales in large US market.
Started: Rich62, 17 Oct 2023 09:58
Last post: ragnarlothbrok, 17 Oct 2023 10:25
I've been buying a small amount of these over the last few days. It is very cheap but so is everything!!
On the plus side 0.5x sales is a huge discount to this type of company in the US. Cant see incidence of premature births being lower given issues around climate and pollution impacting pregnancy
On the negative side profitability is questionable, it was very healthy in 2022 but 2023 and this year looks the same. Lots of non recurring items, inflation pressures and a big chunk of profit goes on interest
The prospect of entering the US is interesting. They obviously have great products but the US is notoriously difficult to penetrate and competition looks pretty fierce
https://www.gminsights.com/industry-analysis/neonatal-ventilators-market#:~:text=Based%20on%20mobility%2C%20the%20neonatal,at%20over%20USD%20222.7%20million.
Is it possible that the only buyers of these shares are the directors and when they stop it might start its downward trend
The chart is truly horrendous, well below its all time low!
CFO buys 19577 shares at 35.5p.
Hopefully the Directors will tag team these buys and take share price back over 40p.
Still a daft price for such a solid business.
Started: Rich62, 16 Oct 2023 08:24
Last post: Rich62, 16 Oct 2023 08:24
Decent sized Director buys - especially Chair who bought 100k shares at 32.95p
Bargain at these prices. Don't understand why anyone off loaded at below 30p, ludicrous decision, must be desperate for cash.
Started: ShareSocUK, 14 Oct 2023 11:37
Last post: ShareSocUK, 14 Oct 2023 11:37
ShareSoc is holding its first hybrid event in London on 19th Oct! Hear from Inspiration Healthcare Group (IHC) and other healthcare companies like Tristel Plc (TSTL), Creo Medical Group (CREO), Abingdon Health (ABDX) and GENincode (GENI). 📍🌐 Attend in-person or online. Register: https://bit.ly/3FbyXfe
Started: Rich62, 11 Oct 2023 18:27
Last post: Rich62, 11 Oct 2023 18:27
Obviously a larger selling off loading some shares - today the market makers walked the price down hard (10%) down to 30/28.5p on hardly any volume. Decent sized buys came in at 29-30p, but share price hardly lifted at all. After close market makers blended in, a 53,500 sell at 29p. These guys are always less than transparent and love their little games, don't they?..
Now the crazy thing is the business is worth just £20m now - down 80% off peak of 150p/share. Okay revenues have flatlined, margins tightened and company probably spent too much on tech centre - but worth only 20% of previous market cap??? Really??
They've also done some bold stuff, like reducing office space, headcount etc with the relocation / centralisation of business. Should pay off this year, now that's been done.
A bargain at 30p, but then there are so many ridiculously undervalued shares out there right now.
Got to be hostile takeover bid by PE at this price surely?
Started: LesBoy, 18 Jun 2023 08:46
Last post: poole, 31 Jul 2023 12:00
Further to my last post It would appear that an institutional investor is still selling - most likely some part of Premier Miton.
Is it 'The Diverse Income Trust' which was last reported as below 3% or some other part of Premier Miton? If neither then who?
Any thoughts please?
There does seem to be an institutional investor still reducing there holding that has been a drag on the shares.
Thanks Lesboy for reporting 'The Times' share tip - as not all shareholders read 'The Times' though from today's reaction clearly some shrewd investors do!
Is it co-incidence that the company is presenting a belated post results update this afternoon around 3pm on the 'Investor Meets Company' forum? - and an AGM later this month.
From today's Times:
Inspiration Healthcare’s share price chart would bring doctors running if it flashed up on monitors in the hospitals where its intensive care products are used. From 68p in 2020, the firm, which specialises in neonatal medical machines and aids, saw its stock more than double in the following 12 months before crashing back down to 84p over distribution issues in China last November and halving again to 45p now.
It’s either an ideal time to snap up a bargain in this Crawley-based medtech distributor — or it’s a dud that was overvalued in the Covid years, when its ventilators saw high demand from the NHS. Which is correct?
Inspiration was founded in 2003, and listed on Aim in 2015 via a reverse takeover of Inditherm, which specialises in technology that warms up very sick patients. Today, Inspiration’s key products include the all-in-one SLE6000 ventilator, non-invasive ventilators for babies and cerebral function monitoring systems; the firm sells its own UK-made products in 75 countries, generating 60 per cent of profits from overseas. Its neonatal market specialism is seeing growing demand: more than 15 million babies are born prematurely every year, but that figure is rising worldwide. The neonatal intensive care market is worth $6.8 billion and set to approach $10 billion by 2027, according to analysts ResearchandMarkets.com.
Yet Inspiration’s own trends have not reflected that opportunity. Results for the year to February were muted, with revenues almost flat at £41 million and underlying earnings falling from £6 million a year earlier to £4 million. Chief executive Neil Campbell said the firm had shown “resilience”, a barrel-scraper of a verdict.
There are reasons for cheer: Inspiration invested in a new manufacturing and technology centre in Croydon, increasing both its capacity and capability. It has reliable, high-quality customers, and revenues picked up in the fourth quarter of its last financial year, and amounted to almost £2 million cash in the first two months of its 2024 year. Its policy of investing about 9per cent of sales into R&D should gradually pay off.
Seb Jantet, analyst at house broker Liberum, is realistic: “the recent track record and poor cash generation warrant some caution,” he says, but names a punchy 100p target price because “Inspiration’s core offering is sound and … we expect the discount to peers to close.”
The price to earnings ratio is 9.6 for 2023, down from over 12 last year. Inspiration is a dicey investment, but its medical technology’s time has come: buy.
Started: Rich62, 19 Jun 2023 11:42
Last post: Rich62, 19 Jun 2023 11:42
The Times share tip is handy in giving whoever is selling down IHC, plenty of liquidity to sell into.
Already 342,000 shares traded. Hopefully once the seller is out, IHC can move on upwards, just needs a couple of decent contract wins.
Started: Hibas19, 7 Jun 2023 11:44
Last post: Hibas19, 7 Jun 2023 11:44
Were we supposed to get a trading update today? The rns about the investor day mentioned it would include a trading update, would they would not also have to also rns the update? Unless I've misunderstood the rns..
This share must be at the bottom now.....
Started: Troajan, 18 Feb 2023 15:22
Last post: Troajan, 18 Feb 2023 15:22
You get everywhere mag lol. I don't care what they say, I quite like your posts!!!
This one looks good,
doing some more dd later
have plenty of orders
Just bought back in. Always liked this company. Gla.
Yeah I’m a master of the art form of understatement. A better description would be an absolute shocker of a RNS. I await the results with trepidation
Bit of an understatement that Herring!
Started: DSFLAT, 26 Oct 2022 13:11
Last post: DSFLAT, 27 Oct 2022 10:59
Further to my post yesterday and having spoken with IHC the reason for the confusion was due to having a new high tech phone system being installed at the time of my call and the receptionist also being new to the position.
The receptionist was very polite and helpful and having spoken with a member of the sales team today I feel very confident that IHC are experts in their field and will deliver great results for Genedrive.
I just rang to see if I could speak to someone about the Genedrive MT-RNR1 kit and I wasn't that impressed tbh.
Seemed very chaotic and unsure of what I was talking about.
The Genedrive MT-RNR1 kit is advertised on the IHC website so I had expected the receptionist to know what it was.
Perhaps I caught them at a bad time but I hope for GDR's sake these guys are capable of delivering results.
Started: Troajan, 5 Oct 2022 16:08
Last post: Troajan, 5 Oct 2022 16:08
Started: Bazzaman, 4 Oct 2022 18:14
Last post: Bazzaman, 4 Oct 2022 18:14
Started: poole, 4 Oct 2022 14:00
Last post: poole, 4 Oct 2022 14:00
Announcement includes the 2nd mention of £0.6m Japanese order for delivery this financial year yet 1st mention of two rather larger orders (each around £1.3m) to Iraq & Egypt respectively. Are those to be delivered in 2nd half of this year or were they delivered in whole or part the 1st half ?
Last post: worksdept, 4 Oct 2022 10:59
Yes not what we wanted to SEE!
But have modern new production facilties and stock
Poor HI results. Revenue slightly down at £20.5m (LY HI 20.9m) but margins lower at 45.1% (LY 52.5%), Operating profit £1.1m (LY £2.6m) and cash at £3.3m (LY £8.6m). Cash down due to expansion costs and building inventory for H2.
Had been a fan and holder here for several years but sold this morning, before share price collapsed 15%.
May come good in H2, but too many risks with wider economy at present.